No Data
No Data
No Data
Milight One updates its high price [New high price and new low price updated stocks].
The stocks that reached new highs on the Tokyo Main Board are Mirait One <1417> and Ando Hazama <1719>, totaling 55 stocks. The stocks that reached new lows on the Tokyo Main Board are Fujiya <2211> and Rohto Pharmaceutical <4527>, totaling 6 stocks. 'Tokyo Main Board' 'Tokyo Standard' 'Tokyo Growth' New Highs New Lows New Highs New Lows New Highs New Lows 02/1355641115002/12512945618202/1037244529202/07451936411302/0
Oriental Shiraishi, Nissui, etc. (additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous After ----------------------------------------------------- <3291> Iida GHD Daiwa "3" "2" <4189> KH Neochem Daiwa "3" "2" <6504> Fuji Electric SMBC Nikko "2" "1" Downgraded - Bearish Code Stock Name Securities Company Previous After --------------------------------------------
Recruit Holdings has revised its 2025/3 operating profit upward to 488 billion yen from 442.7 billion yen.
Recruit Holdings <6098> announced a revision of its financial estimates for the fiscal year ending in March 2025. Revenue has been revised upward from 3 trillion 468.7 billion yen to 3 trillion 560 billion yen, and operating profit has been revised upward from 442.7 billion yen to 488 billion yen. The HR Technology business, centered around the US job search site "Indeed," is performing well, contributing to increased revenue per paid job advertisement. Matching & solutions such as the real estate site "SUUMO" and the beauty reservation site "Hot Pepper View Inc" are also contributing.
Key points of the PTS on the 12th = Rakuten Bank, GMO R&A, Sumitomo Construction.
▽ Rakuten Bank <5838.T>, Earnings Reports and Financial Estimates revisions ▽ GMO R&A <3695.T>, Earnings Reports and Financial Estimates and Dividends forecast revisions as well as the introduction of a Shareholder benefit system ▽ Mizuho Construction <1821.T>, Earnings Reports and Financial Estimates revisions ▽ Japan Electrical Construction <1950.T>, Dividend increase and share buyback ▽ JGC HD <1963.T>, Earnings Reports and Financial Estimates revisions ▽ Sasmmed <4263.T>, achievement of milestones related to a joint research and development and sales agreement with Aska Pharmaceutical ▽ SIGG <
Rohto Pharmaceutical Reports Q3 Sales Growth Amidst Profit Challenges
Rohto Pharmaceutical Co. Increases Year-End Dividend Forecast